Indication
Klebsiella pneumoniae bronchitis
*Klebsiella pneumoniae* bronchitis is a lower respiratory tract infection characterized by acute or subacute inflammation of the bronchial tree caused by the Gram-negative opportunistic bacterium *Klebsiella pneumoniae*. Read more about Klebsiella pneumoniae bronchitis
7 drugs 7 manufacturers
Drugs that treat it
Common Klebsiella pneumoniae bronchitis therapies.
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Klebsiella pneumoniae* bronchitis is a lower respiratory tract infection characterized by acute or subacute inflammation of the bronchial tree caused by the Gram-negative opportunistic bacterium *Klebsiella pneumoniae*.
It primarily occurs in hospitalized patients, immunocompromised individuals, elderly adults, or those with underlying chronic respiratory illnesses such as chronic obstructive pulmonary disease or bronchiectasis.
Pathophysiologically, the bacterium colonizes and invades the mucosal lining of the bronchi, where its thick polysaccharide capsule impedes phagocytosis and incites a pronounced neutrophilic inflammatory response.
Defining clinical manifestations include persistent cough, purulent sputum production, fever, wheezing, and dyspnea, typically occurring in the absence of frank alveolar consolidation.
- nih.gov
*Klebsiella pneumoniae* bronchitis is a lower respiratory tract infection characterized by acute or subacute inflammation of the bronchial tree caused by the Gram-negative opportunistic bacterium *Klebsiella pneumoniae* Pathophysiologically, the bacterium colonizes and invades the mucosal lining of the bronchi, where its thick polysaccharide capsule impedes phagocytosis and incites a pronounced neutrophilic inflammatory response
- ersnet.org
*Klebsiella pneumoniae* bronchitis is a lower respiratory tract infection characterized by acute or subacute inflammation of the bronchial tree caused by the Gram-negative opportunistic bacterium *Klebsiella pneumoniae* It primarily occurs in hospitalized patients, immunocompromised individuals, elderly adults, or those with underlying chronic respiratory illnesses such as chronic obstructive pulmonary disease or bronchiectasis
- nih.gov
It primarily occurs in hospitalized patients, immunocompromised individuals, elderly adults, or those with underlying chronic respiratory illnesses such as chronic obstructive pulmonary disease or bronchiectasis Defining clinical manifestations include persistent cough, purulent sputum production, fever, wheezing, and dyspnea, typically occurring in the absence of frank alveolar consolidation
- nih.gov
Pathophysiologically, the bacterium colonizes and invades the mucosal lining of the bronchi, where its thick polysaccharide capsule impedes phagocytosis and incites a pronounced neutrophilic inflammatory response
- doralhw.org
Defining clinical manifestations include persistent cough, purulent sputum production, fever, wheezing, and dyspnea, typically occurring in the absence of frank alveolar consolidation
Personalize your experience
Follow Klebsiella pneumoniae bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.